Speaker illustration

Doctor Jennifer Hsiang-Ling Lin

Titusville (United States of America)

Risk of stroke overall and by stroke severity among newly diagnosed non-valvular atrial fibrillation patients initiating treatment with rivaroxaban versus warfarin

Event: ESC Congress 2018

Topic: Oral Anticoagulation

Session: Atrial fibrillation - Stroke prevention


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb